AliveX Biotech Showcases AI-Driven Multi-Omics Platform at the 3rd Multi-Omics Research and Clinical Application Conference

On July 7, 2024, the 3rd Multi-Omics Research and Clinical Application Conference concluded successfully in Beijing. The conference was filled with a strong academic atmosphere, with all seats occupied. Numerous experts and scholars engaged in in-depth and enthusiastic discussions and exchanges on the theme of "Focusing on Multi-Omics: From Research to Clinical Practice."Professor Leimin Chen, Chief Scientist of AliveX Biotech, was also a special guest and delivered a keynote speech titled "Applications of Lipidomics in Cancer and Neurodegenerative Disease Research" at the sub-forum on "New Advances in the Development and Clinical Application of Metabolomics."

Speaker Biography

Professor Lemin Chen, Chief Scientist of AliveX Biotech, provides an in-depth analysis of the fundamental principles of lipidomics, highlighting its role as a key to unlocking disease mechanisms. By discussing breakthrough advancements in using lipidomics as potential biomarkers for early cancer diagnosis, as well as innovative research in understanding the pathogenesis of Alzheimer's disease, the importance of lipidomics in the application to cancer and neurodegenerative diseases is further emphasized.With the establishment of AliveX Biotech's AI multi-omics + mechanism modeling platform, lipidomics has achieved greater breakthroughs, not only advancing the rapid transformation from basic research to clinical applications but also providing new perspectives and tools for precision medicine.

At this industry盛会, the booth of AliveX Biotech was crowded with visitors. Many attendees gathered around our exhibition stand, showing great interest and curiosity in the cutting-edge technology platforms displayed by our company. Particularly, our AI bio-computing platform sparked heated discussions and a wave of inquiries regarding its application in scientific research solutions.AliveX Biotech's AI experts explained in detail how the AI computing platform brings breakthrough insights into multi-omics data analysis, disease mechanism research, and the identification and evaluation of biomarkers, enhancing R&D efficiency.

At this conference, AliveX Biotech launched the "Ten Million Research Funding Plan."Recruit partners to jointly conduct innovative and cutting-edge scientific research in the fields of oncology, autoimmune diseases, metabolic diseases, and neurodegenerative diseases.